Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nestlé
Biotech
Seres Therapeutics' microbiome therapy flops against placebo
There’s been precious little good news for Seres Therapeutics of late, and the woe continues today as it records another trial failure.
Ben Adams
Jul 22, 2021 7:30am
Nestlé, Seres re-up microbiome partnership in $175M deal
Jul 1, 2021 12:00pm
Senda drives 3 programs to clinic with bumped-up $98M series B
Jun 10, 2021 8:00am
Promising safety, a tiny widget creates chaos for tube feeders
Dec 16, 2019 11:20am
NEJM paper buoys Aimmune’s peanut allergy drug prospects
Nov 19, 2018 9:43am
With $98M investment, Nestlé bumps up Aimmune stake to 19%
Nov 12, 2018 4:28pm
